A biotech funding story about a startup scaling AI-native drug discovery and building biological foundation models; a look at its R&D strategy and platform.
Key Takeaways
- 10, 2026 /PRNewswire/ -- Aureka Biotechnologies announced the close of a US$100 million Series B financing on Aug
- Aureka has now raised nearly US$200 million to date
- Aureka will also upgrade Lab-in-the-Loop